About Icon Genetics
Icon Genetics is a company based in Halle (Germany) founded in 1999 was acquired by Denka in August 2015. Icon Genetics has raised $14.6 million across 2 funding rounds from investors including Denka, IBG Beteiligungsgesellschaft Sachsen-Anhalt and CFH. The company has 25 employees as of December 31, 2021. Icon Genetics offers products and services including magnICON® Platform and Recombinant Proteins. Icon Genetics operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Algenex, among others.
- Headquarter Halle, Germany
- Employees 25 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Icon Genetics Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Icon Genetics
Icon Genetics offers a comprehensive portfolio of products and services, including magnICON® Platform and Recombinant Proteins.
Technology for transient expression of recombinant proteins in plants.
Proteins for vaccines and diagnostics via plant-based production.
Funding Insights of Icon Genetics
Icon Genetics has successfully raised a total of $14.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.6 million completed in March 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Icon Genetics
Icon Genetics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Denka, IBG Beteiligungsgesellschaft Sachsen-Anhalt and CFH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Equity partnerships are provided for startups and mid-sized companies in Saxony.
|
Locked | Locked | Locked | |
|
Manufacturer of calcium carbide and chemical fertilizers
|
Locked | Locked | Locked |
Investor details for Icon Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Icon Genetics
Investment portfolio details for Icon Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Icon Genetics
Detailed financials for Icon Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Icon Genetics Comparisons
Peer comparison for Icon Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Icon Genetics
Icon Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Algenex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
UBaaS platform for plant-based recombinant protein bioproduction is offered.
|
|
| Locked | Locked | Locked |
Animal-free growth factors are developed for life science applications.
|
|
| Locked | Locked | Locked |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| Locked | Locked | Locked |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
|
| Locked | Locked | Locked |
Developer of recombinant biologics for animal and human health
|
Detailed competitors of Icon Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Icon Genetics
Complete news archive for Icon Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Icon Genetics
Icon Genetics was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Icon Genetics is headquartered in Halle, Germany. It is registered at Halle, Sachsen-anhalt, Germany.
Icon Genetics is a funded company, having raised a total of $14.6M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Icon Genetics is 25.
Icon Genetics discovers and develops new biopharmaceuticals and high-value protein products using green plants as production hosts. They have developed new generation production platforms and product prototypes for pharmaceutical, animal health and chemical biotech markets. They offer new plant engineering technologies which address speed, yield, precision, expression control and safety of transgene management in plants. Its products include Transgene Operating Systems, a suite of technologies, including nuclear transformation of plants based on translational (promoterless), translation-fusion, and polycistronic vectors, as well as vectors that utilize vector assembly in planta or RNAprotein trans-splicing; plastid transformation that allows construction of transplastomic hosts for high-yield production of specialty proteins in chloroplasts; and pro-viral transfection of plants that provides advantages of fast amplification processes in a plant. The company also offers magnICON system for rapid genevector assembly and optimization, as well as for high yieldhigh throughput expression of genes in planta; lexICON system allows DNA bar-coding of genetically modified plants; and rubICON, a hybrid seed production and trait control system. In January 2006, the Company has been acquired by Bayer Innovation GmbH, a wholly owned subsidiary of Bayer AG. In January 2007,Icon Genetics AG has been merged into Icon Genetics GmbH. In January 2012, ICON has been acquired by Nomad Bioscience GmbH, Munich, Germany. In Aug 2015, the company was acquired by Japans Denka.
Icon Genetics's top competitors include Future Fields, Qkine and Oxford Expression Technologies.
Icon Genetics offers magnICON® Platform and Recombinant Proteins.